摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2-[4-(3-苯基-2H-苯并吡喃-2-基)苯氧基]乙基]哌啶 | 130064-18-5

中文名称
1-[2-[4-(3-苯基-2H-苯并吡喃-2-基)苯氧基]乙基]哌啶
中文别名
——
英文名称
CDRI 85/287
英文别名
2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-(2H)-1-benzo(b)pyran;2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-benzo(b)pyran;CDRI-85/287;1-(2-(4-(3-Phenyl-2H-1-benzopyran-2-yl)phenoxy)ethyl)piperidine;1-[2-[4-(3-phenyl-2H-chromen-2-yl)phenoxy]ethyl]piperidine
1-[2-[4-(3-苯基-2H-苯并吡喃-2-基)苯氧基]乙基]哌啶化学式
CAS
130064-18-5
化学式
C28H29NO2
mdl
——
分子量
411.544
InChiKey
DBHGMZQRJDUFGS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    21.7
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:dd88f15548c61124d7ce68c3695a1ce0
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    二对甲苯酰基-L-酒石酸1-[2-[4-(3-苯基-2H-苯并吡喃-2-基)苯氧基]乙基]哌啶乙醇 为溶剂, 反应 4.0h, 以120 mg的产率得到L-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran-di-p-toluoyl-L-tartrate
    参考文献:
    名称:
    Resolution, molecular structure and biological activities of the d - and l -enantiomers of potent anti-implantation agent, dl -2-[4-(2-Piperidinoethoxy)phenyl]-3-phenyl-2 H -1-benzopyran
    摘要:
    Compound 1 (DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran, CDRI 85/287) a potent anti-estrogen and anti-implantation agent has been successfully resolved into its pure D- and L-enantiomers. Biological studies showed L-enantiomer to be the active form, exhibiting a fivefold higher receptor affinity for the rat uterine cytosolic estrogen receptor, 100% contraceptive efficacy at 1.3 mg/kg dose in single day schedule and 89% inhibition of estradiol induced increase of uterine weight at its contraceptive dose. The absolute stereochemistry determined by X-ray crystallographic analysis showed that the L-enantiomer has 2R configuration at its asymmetric centre.
    DOI:
    10.1016/s0968-0896(99)00131-5
  • 作为产物:
    参考文献:
    名称:
    SHARMA, ARUN P.;SAEED, ASHRAF;DURANI, SUSHEEL;KAPIL, RANDHIR S., J. MED. CHEM., 33,(1990) N2, C. 3216-3222
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Structure-activity relationship of antiestrogens. Effect of the side chain and its position on activity of 2,3-diaryl-2H-1-benzopyrans
    作者:Arun P. Sharma、Ashraf Saeed、Susheel Durani、Randhir S. Kapil
    DOI:10.1021/jm00174a019
    日期:1990.12
    A series of 2,3-diaryl-2H-1-benzopyrans carrying a tertiary aminoethoxy chain at the ortho, meta, or para position of 2-phenyl or an alkyl at position 4 of the pyran ring were synthesized and evaluated for their affinity for estrogen receptor (ER) and for microsomal antiestrogen specific binding site and for their uterotrophic-antiuterotrophic activities in rodents. The analogues bearing the side chain at the para position of 2-phenyl were found to be active while those substituted at the meta and ortho positions were inactive as ER ligands as well as estrogen agonists-antagonists. Among para-substituted ethers, the 2-piperidinoethoxy analogue 5 was found to be a more effective antiestrogen than the corresponding pyrrolidino, dimethylamino, and related analogues. Incorporation of a methyl or an ethyl at C4 in the pyran nucleus was found to increase receptor affinity of the prototypes. The ethyl was also found to potentiate agonist activity of the prototype while abolishing its antagonist activity. The piperidino analogue 5 was found to be a better antiestrogen than tamoxifen as well as LY-117018 in rats as well as mice. The prototypes were also found to have high affinity for the microsomal antiestrogen specific binding sites. The benzopyrans have thus emerged as a new group of potent antiestrogens.
  • 2,3-DIARYL-1-BENZOPYRANS FOR TREATING DERMATITIS
    申请人:ZymoGenetics, Inc.
    公开号:EP0737068A1
    公开(公告)日:1996-10-16
  • US5389646A
    申请人:——
    公开号:US5389646A
    公开(公告)日:1995-02-14
  • US5416098A
    申请人:——
    公开号:US5416098A
    公开(公告)日:1995-05-16
  • US5552413A
    申请人:——
    公开号:US5552413A
    公开(公告)日:1996-09-03
查看更多